This is because the cardinal symptom, dyspnoea, is shared with many more common
diseases, and the signs of pulmonary hypertension are difficult to elicit for the non-specialist …

Pulmonary hypertension was previously considered a rare untreatable condition. The past
two decades have seen major changes in our understanding of the spectrum of disease …

Pulmonary hypertension is a progressive and often fatal cardiopulmonary condition
characterised by increased pulmonary arterial pressure, structural changes in the pulmonary …

Consensus statement on the management of pulmonary hypertension in clinical practice in the
UK and Ireland | Heart Skip to main content Viewing from: Google Indexer BMJ Journals …

Therapeutic options for pulmonary arterial hypertension (PAH) have increased over the last
decades. The advent of pharmacological therapies targeting the prostacyclin, endothelin …

Pulmonary hypertension (PH) is a serious and progressive lung disease, defined by
elevation of pulmonary arterial pressure. Affected patients are often disabled by symptoms of …

Pulmonary hypertension comprises a family of disorders occurring as a primary disease or
as a complication of a large number of respiratory and cardiac diseases. Pulmonary …

Background Primary pulmonary hypertension is a progressive disease for which no
treatment has been shown in a prospective, randomized trial to improve survival. Methods …

Primary pulmonary hypertension (PPH) is a disease associated with significant morbidity
and mortality that occurs most commonly in young and middle aged women. 1 Until recently …

* In these instances, treatment is best aimed at the underlying disease. These patients do
not usually require specialist assessment, but those with certain forms of PH with lung …